Homepage
Medication Guide
Eligible Populations for Canakinumab (ILARIS)
Canakinumab (ILARIS) is an innovative biotherapeutic drug that is playing an increasingly important role in the medical field. It is mainly used to treat a variety of inflammatory diseases, bringing n...
502
Friday, August 8th, 2025, 16:05
Canakinumab: Instructions, Medical Insurance, Price, Efficacy, and Side Effects
Canakinumab, mainly used for the treatment of various autoinflammatory diseases and gout, is an innovative biological agent whose unique efficacy has been widely recognized by the international medica...
502
Friday, August 8th, 2025, 16:00
How to buy canakinumab?
Canakinumab, also known as canakinumab, Ilaris. Developed by Novartis of Switzerland, it is an effective therapeutic drug for various autoinflammatory diseases and gout. Its purchasing channels, price...
501
Friday, August 8th, 2025, 15:52
What is the latest price of canakinumab in 2025?
Canakinumab is an effective therapeutic drug for various autoimmune diseases, Still's disease, and gout. Its price, purchasing channels, and storage methods have always been the focus of patients&...
502
Friday, August 8th, 2025, 15:48
Who is the manufacturer of Fyarro(Nab-Sirolimus) albumin?
Sirolimus albumin is a doxetine drug that works by inhibiting the growth and division of cancer cells. Studies have found that the drug has a higher concentration in tumor tissue, which means that mor...
500
Monday, July 28th, 2025, 17:44
Precautions for Fyarro(sirolimus) Albumin (Fyarro)?
Fyarro(sirolimus) albumin, which was approved by the US Food and Drug Administration in November 2021, can be used to treat malignant perivascular epithelioid cell tumors. As an mTOR inhibitor, w...
502
Monday, July 28th, 2025, 17:36
How to use Fyarro(sirolimus) albumin
Fyarro(sirolimus) albumin has shown significant effectiveness in the treatment of malignant perivascular epithelioid cell tumors, not only improving the survival rate of patients, but also having...
503
Monday, July 28th, 2025, 17:10
Diseases that may be caused by the use of Fyarro(sirolimus) albumin
Fyarro(sirolimus) albumin (Fyarro) is a drug developed by Edison Pharmaceuticals (AADI) in the United States. The following mainly explains the diseases that may be caused by the use of Fyarro(si...
502
Monday, July 28th, 2025, 16:54
The survival time of malignant perivascular epithelioid cell tumors exceeds 3 years
In the human body, TSC1 and TSC2 proteins inhibit mammalian target of rapamycin (mTOR) in the form of a complex. Studies have shown that in malignant perivascular epithelioid cell tumors, there is act...
500
Monday, July 28th, 2025, 16:46
What is Fyarro(sirolimus) albumin?
Fyarro(sirolimus) albumin is a new drug that has been verified by scientific research and clinical trials. Through research and experiments, Fyarro(sirolimus) albumin has been proven to have...
503
Monday, July 28th, 2025, 16:36
126 / 187
1862 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved